Skip to content
Recall Observatory FDA recall evidence

Drug product

Lorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per carton (NDC 0641-6044-25), Rx only, Manufactured by West-Ward, Eatontown, NJ 07724.

D-0574-2023

May 11, 2023

Class II

Product summary

Firm
Hikma Pharmaceuticals USA Inc.
Event
Event 92320
Status
Terminated
Classification
Class II
Quantity
1,352,475 vials
Official record key
drug-enforcement:D-0574-2023

Official wording

Reason: Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during retain steting due to the elevated Related Compound-C.

Code information: Lots: 070086, 070128, Exp. 07/2023

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out-of-specification